Clinical trial
Evaluation of the Utility of OCT Angiography in Assessing Vascular Perfusion in Rare Retinal and Choroidal Diseases
NCT02141308 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Utility of OCT Angiography in Assessing Vascular Perfusion in Rare Retinal and Choroidal Diseases
- Lead sponsor
- Oregon Health and Science University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 31, 2014
- Completion date
- December 31, 2026
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
central serous chorioretinopathy, juxtafoveal telangiecasia, polypoidal choroidal vasculopathy, retinal arterial macroaneurysm, retinal artery occlusions